Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Terapevticheskii Arkhiv|October 26, 2022
[Acute decompensation of heart failure: state of the problem]I V Zhirov, S N Nasonova, S N TereshchenkoTerapevticheskii Arkhiv|October 26, 2022
[SGLT2 inhibitors in acute decompensated heart failure, what do we know?]A E Lapteva, S N Nasonova, I V Zhirov, et al.Terapevticheskii Arkhiv|February 18, 2026
[Effect of sodium-glucose cotransporter type 2 inhibitors on the course of heart failure in patients with amyloid cardiomyopathy: Results of a pilot single-center randomized trial]A A Shoshina, S N Nasonova, I V Zhirov, et al.Terapevticheskii Arkhiv|October 26, 2022
[Prognostic impact of uric acid in patients with acute decompensated heart failure]S N Nasonova, A E Lapteva, I V Zhirov, et al.Kardiologiia|September 22, 2021
[Remote monitoring of patients with heart failure in real clinical practice]S N Nasonova, A E Lapteva, I V Zhirov, et al.Kardiologiia|November 29, 2011
[The role of hypotension as a factor of unfavorable prognosis in patients with chronic heart failure]L G Kapanadze, A A Petrukhina, S N Nasonova, et al.Terapevticheskii Arkhiv|October 26, 2022
[Pro-inflammatory cytokines in chronic cardiac failure: state of problem]A A Korotaeva, E V Samoilova, D R Mindzaev, et al.Bulletin of Experimental Biology and Medicine|April 12, 2023
Dynamics of the Levels of Interleukin 6, Its Soluble Receptor, and Soluble Glycoprotein 130 in Patients with Chronic Heart Failure and Preserved or Reduced Ejection FractionA A Korotaeva, E V Samoilova, I V Zhirov, et al.Kardiologiia|May 8, 2020
[Experience with tafamidis in a patient with transthyretin amyloidosis]S N Nasonova, I V Zhirov, M M Magomedov, et al.Kardiologiia|December 29, 2025
Interleukin-1 Signalling Inhibitors in Heart Failure With Preserved and Reduced Ejection FractionE V Samoilova, D А Chepurnova, S N Nasonova, et al.Pageof 3